These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24754184)

  • 1. [Prudent use price controls in Chinese medicines market: based on statistical data analysis].
    Yang G; Wang N; Huang LQ; Qiu HY; Guo LP
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):144-8. PubMed ID: 24754184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Price adjustment for traditional Chinese medicine procedures: Based on a standardized value parity model.
    Wang H; Jin C; Jiang Q
    Biosci Trends; 2017 Nov; 11(5):524-532. PubMed ID: 29070761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking resource supplies and price drivers: Lessons from Traditional Chinese Medicine (TCM) price volatility and change, 2002-2017.
    Cunningham AB; Long X
    J Ethnopharmacol; 2019 Jan; 229():205-214. PubMed ID: 30339980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discussion on releasing price of Chinese patent medicine to market economy to achieve sustainable development].
    Long X; Huang L; Jiang E; Zhou Y; Xu Y; Zheng S; Ning X; Liu H; Chen L
    Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(3):397-401. PubMed ID: 22568248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on supply and demand relation based on two stages division of market of Chinese materia medica].
    Yang G; Guo LP; Wang N; Zeng Y; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(2):328-33. PubMed ID: 24761655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis and design of signaling transfer mechanism based on third-party certification: quality prestige index of traditional Chinese medicine enterprises].
    Yang G; Wang N; Guo LP; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):925-8. PubMed ID: 25204192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Theory of toxic classification of traditional Chinese medicine and recommendations for revision of China pharmacopeia (volume 1)].
    Zhao J; Ye Z
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2193-8. PubMed ID: 23189716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research on competitiveness of traditional Chinese medicine industry's international trade based on diamond theory].
    Cheng M; Yang G; Chi XL; Xin MT
    Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(1):199-203. PubMed ID: 30868833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretrovirals for low income countries: an analysis of the commercial viability of a highly competitive market.
    Nakakeeto ON; Elliott BV
    Global Health; 2013 Feb; 9():6. PubMed ID: 23410145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for market expansion: medical services of Traditional Chinese Medicine.
    Wang Z; Li Z
    J Tradit Chin Med; 2013 Apr; 33(2):280-2. PubMed ID: 23789232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis on influential factors in China's exports of primary and semi-finished products of traditional Chinese medicine to ASEAN].
    Qian YX; Yang Y; Zhao W; Bi KS
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1321-5. PubMed ID: 25011277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Price adjustment in the hospital sector.
    Miraldo M; Siciliani L; Street A
    J Health Econ; 2011 Jan; 30(1):112-25. PubMed ID: 20952080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on early-warning of Chinese materia medica price base on ARMA model].
    Chang F; Mao YD
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1721-3. PubMed ID: 25095391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perception, Price and Preference: Consumption and Protection of Wild Animals Used in Traditional Medicine.
    Liu Z; Jiang Z; Fang H; Li C; Mi A; Chen J; Zhang X; Cui S; Chen D; Ping X; Li F; Li C; Tang S; Luo Z; Zeng Y; Meng Z
    PLoS One; 2016; 11(3):e0145901. PubMed ID: 26930487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation point of rational drug use of traditional Chinese medicine in market].
    Gao R; Sun M; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2807-10. PubMed ID: 22292371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of branded prescription medicine prices in OECD countries.
    Kanavos PG; Vandoros S
    Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There "ain't no mountain high enough"?: The drivers, diversity and sustainability of China's Rhodiola trade.
    Cunningham AB; Li HL; Luo P; Zhao WJ; Long XC; Brinckmann JA
    J Ethnopharmacol; 2020 Apr; 252():112379. PubMed ID: 31743765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence and countermeasure of technical barriers to trade on traditional Chinese medicine industry].
    Gao J; Dong L; Song ZH
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2214-7. PubMed ID: 24079257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.